HIV-Tat regulates macrophage gene expression in the context of neuroAIDS
Open Access
- 22 June 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (6) , e0179882
Abstract
Despite the success of cART, greater than 50% of HIV infected people develop cognitive and motor deficits termed HIV-associated neurocognitive disorders (HAND). Macrophages are the major cell type infected in the CNS. Unlike for T cells, the virus does not kill macrophages and these long-lived cells may become HIV reservoirs in the brain. They produce cytokines/chemokines and viral proteins that promote inflammation and neuronal damage, playing a key role in HIV neuropathogenesis. HIV Tat is the transactivator of transcription that is essential for replication and transcriptional regulation of the virus and is the first protein to be produced after HIV infection. Even with successful cART, Tat is produced by infected cells. In this study we examined the role of the HIV Tat protein in the regulation of gene expression in human macrophages. Using THP-1 cells, a human monocyte/macrophage cell line, and their infection with lentivirus, we generated stable cell lines that express Tat-Flag. We performed ChIP-seq analysis of these cells and found 66 association sites of Tat in promoter or coding regions. Among these are C5, CRLF2/TSLPR, BDNF, and APBA1/Mint1, genes associated with inflammation/damage. We confirmed the association of Tat with these sequences by ChIP assay and expression of these genes in our THP-1 cell lines by qRT-PCR. We found that HIV Tat increased expression of C5, APBA1, and BDNF, and decreased CRLF2. The K50A Tat-mutation dysregulated expression of these genes without affecting the binding of the Tat complex to their gene sequences. Our data suggest that HIV Tat, produced by macrophage HIV reservoirs in the brain despite successful cART, contributes to neuropathogenesis in HIV-infected people.Keywords
Funding Information
- Pilot Funding from Einstein (Epigenomics Shared Facility for massively-parallel sequencing assays)
- National Institutes of Health (R01MH075679)
- National Institutes of Health (R01MH090958)
- National Institutes of Health (R01MH077542)
- National Institutes of Health (R21MH102113)
This publication has 126 references indexed in Scilit:
- The Control of HIV Transcription: Keeping RNA Polymerase II on TrackCell Host & Microbe, 2011
- ProBDNF inhibits infiltration of ED1+ macrophages after spinal cord injuryBrain, Behavior, and Immunity, 2010
- Chromatin dynamics associated with HIV-1 Tat-activated transcriptionBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2010
- Cognitive Neuropsychology of HIV-Associated Neurocognitive DisordersNeuropsychology Review, 2009
- TSLP regulates intestinal immunity and inflammation in mouse models of helminth infection and colitisJournal of Experimental Medicine, 2009
- Epitope tagging of endogenous proteins for genome-wide ChIP-chip studiesNature Methods, 2008
- HIV-tat induces formation of an LRP–PSD-95– NMDAR–nNOS complex that promotes apoptosis in neurons and astrocytesProceedings of the National Academy of Sciences, 2007
- Foxp3 occupancy and regulation of key target genes during T-cell stimulationNature, 2007
- HIV-1 gp120 Compromises Blood–Brain Barrier Integrity and Enhance Monocyte Migration across Blood–Brain Barrier: Implication for Viral NeuropathogenesisJournal of Cerebral Blood Flow & Metabolism, 2007
- Requirement for SWI/SNF chromatin‐remodeling complex in Tat‐mediated activation of the HIV‐1 promoterThe EMBO Journal, 2006